After a series of staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to be a more limited move centered on the Swiss drugmaker’s biomedical research arm.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
After a series of staff consolidation moves in recent weeks, Novartis is again trimming its ranks, albeit in what appears to be a more limited move centered on the Swiss drugmaker’s biomedical research arm.